Tag:

HyperAcute Pancreas

Latest Headlines

Latest Headlines

NewLink Genetics takes the stage at ASCO

June 7, 2012 | By
NewLink Genetics presented updates on its cancer vaccines, HyperAcute Pancreas (algenpantucel-L) and HyperAcute Lung (tergenpumatucel-L), at the American Society of Clinical Oncology 2012 Annual Meeting.

Vax-chemo combo offers some hope in pancreatic cancer

May 24, 2012 | By
Pancreatic cancer is hard to treat, but adding a cancer vaccine to standard chemotherapy could boost survival.
Related Tags
Press Releases
  • Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks
  • Study: Once-Weekly Trulicity™ (dulaglutide) Provides Greater Blood Sugar Reduction Compared to Once-Daily Victoza® (liraglutide) in Japanese Patients after 52 weeks
  • Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
  • Basal Insulin Peglispro Studies Demonstrate Superiority to Insulin Glargine Across Multiple Measures in People with Type 1 Diabetes
  • Lilly's Basal Insulin Peglispro Shows Superiority to Insulin Glargine in Reducing HbA1c in People with Type 2 Diabetes
  • More Press Releases
Sponsored Links